Ghost Ileostomy Versus Protective Ileostomy in Rectal Cancer Followed by Low Anterior Resection: A Randomized Feasibility Trial
Health Science Reports · 2025-10 · 8 (10)
DOI: 10.1002/hsr2.71351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 13.10.2025. Verfasst von Seyed Mostafa Meshkati Yazd und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery Tehran University of Medical Sciences Tehran Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Background
Anastomotic leakage remains a serious concern in rectal cancer patients undergoing neoadjuvant chemoradiotherapy (nCRT) followed by low anterior resection (LAR). To mitigate this risk, protective ileostomy (PI) is often employed; however, it carries its own complications and patient burden. This study aimed to evaluate the feasibility and clinical outcomes of ghost ileostomy (GI) as a potential alternative, aiming to reduce unnecessary stoma creation, related morbidity, readmission rates, and patient discomfort.
Methods
In this randomized, non‐inferiority feasibility trial, patients with rectal cancer who had received nCRT and were scheduled for LAR were enrolled. Feasibility outcomes included recruitment rate, retention, intervention adherence, procedural fidelity, and safety. Safety outcomes compared GI and PI regarding anastomotic leakage and failure, bowel obstruction, acute tubular necrosis (ATN), and readmissions due to complications (primary endpoint).
Results
Eighty patients were randomized from 87 eligible participants, with a recruitment rate of 5.71 patients per site‐month. GI was non‐inferior to PI regarding overall complications and readmissions (one‐tailed 90% CI; power > 80%) and also for obstruction and ATN (one‐tailed 95% CI; power > 80%). However, the PI group had a significantly shorter initial hospital stay than the GI group ( p = 0.042).
Conclusion
This trial supports the feasibility of a definitive future study. GI may serve as a safe and effective alternative to PI in selected low‐risk rectal cancer patients undergoing nCRT and LAR. Larger, multicenter trials are needed to validate these findings and further explore the clinical utility of GI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Colorectal Surgery, Department of Surgery Tehran University of Medical Sciences Tehran Iran.
- Colorectal Research Center Tehran University of Medical Sciences Tehran Iran.
- School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
- Thoracic and Vascular Surgery Research Center Shiraz University of Medical Sciences Shiraz Iran.
ORCID-Profile: Reza Shahriarirad
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Meshkati Yazd, S. M., Keramati, M. R., Ghanbari Ghalerudkhani, M., Shahriarirad, R., Parsa, A., & Keshvari, A. (2025). Ghost Ileostomy Versus Protective Ileostomy in Rectal Cancer Followed by Low Anterior Resection: A Randomized Feasibility Trial. Health Science Reports, 8(10). https://doi.org/10.1002/hsr2.71351
Vancouver
Meshkati Yazd SM, Keramati MR, Ghanbari Ghalerudkhani M, Shahriarirad R, Parsa A, Keshvari A. Ghost Ileostomy Versus Protective Ileostomy in Rectal Cancer Followed by Low Anterior Resection: A Randomized Feasibility Trial. Health Science Reports. 2025;8(10). doi:10.1002/hsr2.71351
BibTeX
@article{MeshkatiYazd2025,
author = {Meshkati Yazd, Seyed Mostafa and Keramati, Mohammad Reza and Ghanbari Ghalerudkhani, Marzieh and Shahriarirad, Reza and Parsa, Amir and Keshvari, Amir},
title = {Ghost Ileostomy Versus Protective Ileostomy in Rectal Cancer Followed by Low Anterior Resection: A Randomized Feasibility Trial},
journal = {Health Science Reports},
year = {2025},
volume = {8},
number = {10},
doi = {10.1002/hsr2.71351}
}
EUVIMED